# PM Peer Review: F2 Formulary Data Source Integration

## Skill Vesion

v1.2

## Review Verdict

APPROVE WITH CHANGES

## Top Findings

**S0 Issues:**
- Data source architecture contradicts stakeholder guidance - PRD lacks specific data source despite transcript clearly recommending against direct RxFlex connection and favoring internal sources

**S1 Issues:**
- Missing integration with existing Darwin/Gemini/Abarka infrastructure revealed in stakeholder discussion
- Success metrics are unmeasurable and lack baselines, targets, and measurement windows
- Formulary-benefits mapping complexity not addressed despite transcript showing critical EOC integration requirements
- Validation approach misaligned with established Customer Service QA process specified in transcript
- Missing key stakeholder dependencies (Selena Wong's team) and technical integration points

**S2 Issues:**
- Q2 timeline alignment and stakeholder notification requirements not documented per transcript discussion

## Findings Table

| Severity | Section | Issue | Why it matters | Recommended fix |
| --- | --- | --- | --- | --- |
| S0 | Proposed Solution | Data source architecture unspecified despite stakeholder guidance against RxFlex direct connection. Transcript clearly recommends Experience Cube or Book of Records as internal data sources. | Cannot proceed to implementation without resolving fundamental architectural contradiction with stakeholder technical guidance. | Replace "discover and integrate" with specific data source selection between Experience Cube and Book of Records per stakeholder recommendations. |
| S1 | Scope / Dependencies | Missing integration with existing Darwin/Gemini/Abarka infrastructure that stakeholders identified as current formulary processing systems. | Ignoring existing systems creates redundant development risk and misaligns with established architecture. | Add dependencies on Selena Wong's team and existing mock adjudication infrastructure. Consider leveraging Gemini interfaces rather than building new systems. |
| S1 | Success Metrics | All success metrics lack baselines, measurement windows, targets, and specific KPI definitions. "Enable medication coverage queries" is not measurable. | Approval reviewers cannot assess target feasibility or success measurement without quantified, time-bound metrics. | Replace with measurable KPIs: formulary query accuracy %, query response time p95, routing precision/recall, each with baseline and weekly measurement windows. |
| S1 | Scope | Formulary-benefits mapping complexity not addressed. Transcript reveals that "different benefits may use the same formulary" with plan-specific coverage variations requiring EOC integration. | Oversimplified scope misses critical business logic complexity, creating implementation and accuracy risk. | Expand scope to include EOC (Evidence of Coverage) integration and benefit-specific formulary interpretation rules. |
| S1 | Definition of Done | Validation approach contradicts transcript guidance. Stakeholders specified Customer Service QA team owns validation using existing quality scorecard criteria. | Misaligned validation approach creates operational handoff risk and ignores established quality processes. | Replace generic validation with specific CS QA team process reference and existing quality scorecard integration. |
| S2 | Timeline / Dependencies | Q2 delivery timeline and end-of-Q2 stakeholder notification requirements from transcript not documented. | Missing timeline coordination may create delivery conflicts with F1 dependencies and stakeholder expectations. | Add Q2 timeline milestones and stakeholder notification requirements before go-live. |

## Missing Decisions

- Which internal data source should be prioritized: Experience Cube or Book of Records as recommended by stakeholders?
- How should the solution integrate with existing Darwin/Gemini/Abarka infrastructure versus building new systems?
- What specific EOC integration approach will handle the formulary-benefits mapping complexity revealed in stakeholder discussion?
- Which business rule categories must be supported for plan-specific formulary interpretation in phase one?
- What are the specific Customer Service QA validation criteria and quality scorecard integration requirements?
- How should Selena Wong's team be engaged for technical capability assessment and integration planning?

## Revision Plan

1. **Resolve data source architecture** - Replace "discover and integrate" with specific selection between Experience Cube and Book of Records per stakeholder guidance
2. **Add existing systems integration** - Document Darwin/Gemini/Abarka dependencies and engagement plan with Selena Wong's team
3. **Expand formulary-benefits complexity** - Add EOC integration requirements and plan-specific coverage interpretation scope
4. **Rewrite success metrics** - Replace unmeasurable goals with specific KPIs including baselines, targets, and measurement windows
5. **Align validation approach** - Specify Customer Service QA team ownership and quality scorecard integration per transcript guidance
6. **Add Q2 timeline coordination** - Document stakeholder notification requirements and F1 dependency sequencing

## Quality Score

42/100. Document contains fundamental architectural misalignment with stakeholder guidance (S0 blocker) and multiple critical gaps in system integration, measurement approach, and scope definition that prevent approval readiness.
